Nurse Practitioner in Meadows Place, TX Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Ms. Nasrin Habibolahy, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 11611 W Airport Blvd Ste 167, Meadows Place, TX 77477 Phone: 281-755-3684 |
Joyce Barragan, Nurse Practitioner - Acute Care Medicare: Not Enrolled in Medicare Practice Location: 11814 Amblewood Dr, Meadows Place, TX 77477 Phone: 832-570-2646 |
News Archive
Pico-Tesla receives ISO certification for Resonator device
Pico-Tesla, The Magneceutical Company, has received the International Organization for Standardization 13485:2003 certificate for the "design, development, production, manufacture and distribution of resonator systems that generate a low-level electromagnetic field for the therapeutic treatment of disease."
Discovery could pave way for new drugs to treat people with memory problems
A team of scientists believe they have shown that memories are more robust than we thought and have identified the process in the brain, which could help rescue lost memories or bury bad memories, and pave the way for new drugs and treatment for people with memory problems.
FDA approves first generic glucagon for injection to treat severe hypoglycemia
Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus.
Johns Hopkins expert says crucial ethics should be considered in HIV cure research
A cure for HIV infection - the International AIDS Society meeting in Kuala Lumpur in early July offered new hope of the possibility, after researchers announced that two "Boston patients" had shown no resurgence of the virus after receiving a bone marrow transplant and ceasing their antiretroviral therapy (ART).
Novel combination of cancer drugs can have therapeutic impact on diffuse large B-cell lymphoma
New research from Roswell Park Cancer Institute shows that promising cancer drugs used in combination can have significant therapeutic impact on a particularly aggressive subtype of diffuse large B-cell lymphoma (DH-DLBCL) in preclinical studies. The researchers will present their findings at the American Association for Cancer Research (AACR) Annual Meeting 2016, to be held April 16-20 in New Orleans.
› Verified 6 days ago